Rising demand for biologic medicines is contributing to the expansion of the Erythropoietin Drug Market. EPO therapies remain important in selected clinical applications involving reduced red blood cell production.
Market Overview
The Erythropoietin Drug Market was valued at US$ 13.14 billion in 2025 and is projected to reach US$ 29.00 billion by 2034, registering a CAGR of 9.19% during...